Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CETP | P11597 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.37 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.37 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3746184 | 0.84 | NPSR1 (0.45) | NPSR1KDM4EMEN1KMT2ACETP | |
| SCHEMBL3746187 | 0.84 | CYP3A4 (0.42) | NPSR1KDM4EMEN1KMT2ACETP | |
| SCHEMBL1434358 | 0.83 | NPSR1 (0.44) | NPSR1KDM4EMEN1KMT2ACETP | |
| SCHEMBL1434360 | 0.83 | EPHX1 (0.46) | NPSR1MEN1KMT2AHTR2AHTR2C | |
| SCHEMBL15016758 | 0.83 | ALDH1A1 (0.43) | NPSR1MEN1KMT2ACYP3A4ADRA2C | |
| SCHEMBL18546019 | 0.82 | NPSR1 (0.43) | NPSR1KDM4ECYP1A2GAAHTT | |
| SCHEMBL5598193 | 0.82 | NPSR1 (0.40) | NPSR1KDM4EKMT2ACYP1A2CYP2C9 | |
| SCHEMBL5598191 | 0.82 | NPSR1 (0.40) | NPSR1KDM4EKMT2ACYP1A2CYP2C9 | |
| SCHEMBL29600101 | 0.82 | NPSR1 (0.40) | NPSR1KDM4EKMT2ACYP1A2CYP2C9 | |
| SCHEMBL30781560 | 0.82 | NPSR1 (0.45) | NPSR1KDM4EMEN1KMT2AOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1399113-B1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING N-ACYLAMINOAMIDE DERIVATIVES | OREAL (FR) | 2007-03-21 | — | — | EP | claimed |
| EP-2836187-B1 | SELF-STANDING COSMETIC SHEET | OREAL (FR) | 2021-12-08 | — | — | EP | disclosed |
| US-9949897-B2 | Self-standing cosmetic sheet | L'OREAL (FR) | 2018-04-24 | — | — | US | disclosed |
| US-20150209243-A1 | SELF-STANDING COSMETIC SHEET | L'OREAL (FR) | 2015-07-30 | — | — | US | disclosed |
| EP-1658838-B1 | Emulsification system for use in cosmetics | ORÉAL L (FR) | 2014-07-02 | — | — | EP | disclosed |
| US-8158136-B2 | Emulsification system for use in cosmetics | L'ORÉAL (FR) | 2012-04-17 | — | — | US | disclosed |
| EP-1892015-A2 | Film showing an improved solubility and cosmetic product comprising said film | L'Oréal (FR) | 2008-02-27 | — | — | EP | disclosed |
| US-20070025939-A1 | cosmetic compositions containing hydroquinone and various sunscreen agents | L'OREAL S.A. (FR) | 2007-02-01 | — | — | US | disclosed |
| US-20070025937-A1 | Cosmetic compositions containing hydroquinone | L'OREAL S.A. (FR) | 2007-02-01 | — | — | US | disclosed |
| WO-2006053790-A1 | USE OF COMPOUNDS OF THE N-ACYLAMINOAMIDE FAMILY AS SOOTHING OR CALMING AGENTS | L'OREAL (FR) | 2006-05-26 | — | — | WO | disclosed |
| WO-2006053789-A1 | PROTECTION OF THE SKIN AGAINST DETERIORATION LINKED TO A STRESS-INDUCED DYSFUNCTION OF THE APOPTOTIC AND IMMUNE DEFENCE PROCESSES | L'OREAL (FR) | 2006-05-26 | — | — | WO | disclosed |
| EP-1658838-A1 | Emulsification system for use in cosmetics | L'OREAL (FR) | 2006-05-24 | — | — | EP | disclosed |
| US-20060039936-A1 | Emulsification system for use in cosmetics | L'OREAL (FR) | 2006-02-23 | — | — | US | disclosed |
| US-20020197289-A1 | Compositions and methods for combating the appearance of ageing | L'OREAL (FR) | 2002-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020197289-A1 | Compositions and methods for combating the appearance of ageing | CYP24A1, CYP27B1, CYP2R1 | NPSR1 4125/4885KDM4E 1294/4885MEN1 4140/4885 |
| US-20070025939-A1 | cosmetic compositions containing hydroquinone and various sunscreen agents | DHX15, HSPA4L, DDX3X | NPSR1 3226/4885KDM4E 768/4885MEN1 2400/4885 |
| US-20150209243-A1 | SELF-STANDING COSMETIC SHEET | CUTA, SUCLG1, SIGLEC7 | NPSR1 800/4885KDM4E 2700/4885MEN1 2314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.